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ABSTRACT 
Objective: Efficacy of natural molecule from Tinospora cordifolia versus commercially available drugs to control diabetes 2. 
Methods: Twelve different drug molecules were selected to study drug properties, bioactivity and detailed mode of action. A comparative study was 
carried out among the drugs and plant metabolite to understand the putative mechanism of metabolite action and its potential to be developed as 
an herbal drug. PharmaGist Server was used to carry out pharmacophore modeling. The sequence of the target molecule (Q09428) was retrieved 
from UniProtKB/SwissProt, and structure prediction was carried out using ITASSER. The best model generated was further refined by energy 
minimization using Deep View. Validation of the structure was performed by Ramachandran plot analysis using PDBSum. Interaction analysis of the 
docked complex was done using LigPlot+. 
Results: The potential of natural plant metabolite to target ATP-binding cassette sub-family C member 8 seems probable based on docking and 
interaction analysis results. The natural molecule showed comparable binding energy (-5.57) in four out of seven drugs. 
Conclusion: Natural molecule from Tinospora cordifolia may serve as a potential lead drug molecule after modification and optimization for 
enhanced interaction. 
Keywords: Diabetes mellitus, Natural molecule, Tinospora, Type 2 diabetes 
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
 
INTRODUCTION 
The type 2 diabetes is a chronic metabolic disorder triggered by 
insulin insensitivity and reduced level of insulin secretion. Insulin is 
a hormone that plays a key role in the transport of glucose to organs 
like the liver. Deficit production of insulin enhances the level of 
glucose in blood [1]. Type 2 diabetes, unlike type 1, is independent 
insulin disorder [2]. As per WHO 2014 factsheet, diabetes is 
prevalent in approximately 9% of adults. Though there is no cure for 
diabetes, drugs that stimulate insulin release are often used to 
regulate glucose absorption in type 2 diabetes patients. 
Sulphonylureas constitute a major group of insulin secreting anti-
diabetic drugs [3]. Sulphonylureas function by targeting ATP-
potassium channels in the membrane of pancreatic beta cells and 
inhibiting potassium efflux. Inhibition of efflux leads to 
depolarization and calcium influx. The influx enhances calcium-
calmodulin binding, kinase activation, and release of insulin-
containing granules by exocytosis. The drugs mimic the activity of 
glucose [4-7].  
However, some findings associated use of sulphonylurea based 
drugs with hypoglycemia and increased risk of heart diseases [8]. 
Natural remedies and nutraceutical are hence preferred these days 
because; they provide the added advantage of minimum adverse 
effects. Tinospora cordifolia (Guduchi) is a medicinal plant that has 
been used since ancient times in the Ayurveda, for the treatment of 
multiple ailments including diabetes [9]. Secondary metabolites and 
active compounds of Tinospora cordifolia have been isolated from 
the plant and, the functions of these molecules have been reported. 
While both stem and root extracts of Tinospora regulate diabetes 
mellitus type 2; stem extract also functions in the regulation of 
diabetic neuropathy [10-13]. However, the detailed mode of action 
of active compounds has not been explored completely. This study 
focused on potential target identification for the insulin secretion 
stimulating active compound of Tinospora cordifolia. A 
comparative analysis has been carried out among the natural 
compound and some marketed sulphonylurea drugs to evaluate 
the applicability of Tinospora as a formulation for the 
development of an effective drug. Drugs used for the treatment of 
diabetes mellitus type 2 were searched in drug bank and 
annotations of the records were compiled.  
Twelve different drug molecules were selected to study drug 
properties, bioactivity (http://www. molinspiration. com) and 
detailed mode of action. Properties viz., Drug Bank accession 
number, log P, polar surface area, the number of atoms, molecular 
weight, the number of polar groups with potential to form Hydrogen 
bonds, the number of violations, rotatable bonds, volume, and target 
of the drugs have been reported below (table1). Out of the twelve 
drugs studied, sulphonylurea class drugs function by blocking ATP-
dependent K+ efflux channel. The blockage leads to depolarization and 
activation of voltage-dependent calcium ion channel and Ca2+ 
Structures (http://www.molinspiration.com) of the sulphonylurea 
molecules were compared [fig.1] for pharmacophore identification; 
pharmacophore modeling was also carried out using the Pharma 
Gist Server [15]. Features of drug molecule reported by Pharma Gist 
were compared with plant metabolite. The sequence of the target 
molecule (Q09428) was retrieved from UniProtKB/SwissProt [16]. 
As the structure of target molecule has not yet been solved and, 
suitable templates with full-length query coverage were not 
identified, structure prediction was carried out using ITASSER [17]. 
In one run, ITASSER accepts query proteins are having less than 1500 
residues so, structure prediction of the target was carried out in two 
separate jobs (position 1-1380 and 1290-1581) with an overlapping 
segment of 90 residues. Care was taken to ensure that regions are 
forming domains based on ProRule annotations [18] were intact as a 
query in one of the jobs. The best models generated by ITASSER were 
used as a template for Modeller9v14 [19] and, one intact model 
involving all the 1581 residues was generated. The best model generated 
was further refined by energy minimization using DeepView [20]. 
influx, 
which eventually stimulates insulin release. A metabolite of Tinospora 
cordifolia has also been reported to stimulate insulin secretion [11] so; 
the comparative study was carried out among the drugs and plant 
metabolite to understand the putative mechanism of metabolite action 
and, potential to be developed as a drug. Properties of the drugs were 
analyzed, DB01251 has molecular weight 527.643Dalton which is not 
desirable according to Lipinski’s rule of five [14]. 
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                  Vol 8, Issue 7, 2016 
Sharma et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 7, 173-175 
174 
Validation of the structure was performed by Ramachandran plot 
analysis using PDBSum [21]. The refined model was used as the receptor 
for docking of the sulphonylurea drugs and natural ligand. Flexible 
docking was carried out using AutoDock4.0 suite [22], PyRx virtual 
screening software (http://pyrx. sourceforge. net/) was used to provide 
a graphical user interface for docking [23]. The structure predicted has 
distinct helix bundle supporting the confirmation of the transmembrane 
domain. The cavity-like structure associated with helix bundle was used 
to define the extracellular region by AutoGrid. LigPlot+ [24] was used for 
analysis of interactions in the docked complex; the plot confirmed the 
interaction of the ligand with residues in extracellular region proposed 
by Locate Database [25]. 
  
Table 1: Comparison of drug properties and targets for 12 approved drugs archived in drug bank and natural plant metabolite molecule 
Drug logP TPSA natoms MW nON nOHNH nviolation nrotb volume Target 
DB01124 2.54 75.27 18 270.35 5 2 0 5 242.79 ATP-binding cassette sub-family C 
member 8 
DB01382 1.19 90.42 21 309.38 7 1 0 7 259.11 ATP-binding cassette sub-family C 
member 8 
DB01251 3.65 121.88 37 527.64 9 2 1 7 469.35 ATP-binding cassette sub-family C 
member 8 
DB01120 1.45 78.5 22 323.42 6 2 0 3 284.59 ATP-binding cassette sub-family C 
member 8 
DB00672 2.21 75.27 17 276.75 5 2 0 4 222.96 ATP-binding cassette sub-family C 
member 8 
DB01016 4.77 113.6 33 494.01 8 3 0 8 424.74 ATP-binding cassette sub-family C 
member 8 
DB01252 3.37 57.61 23 315.41 4 1 0 5 306.03 ATP-binding cassette sub-family C 
member 8 
DB04876 1.42 76.36 22 303.41 5 2 0 3 289.82 Dipeptidyl peptidase 4 
DB04878 -
3.98 
153.62 18 267.28 8 8 1 5 238.17 Dipeptidyl peptidase 4 
DB06292 2.59 99.38 28 408.88 6 4 0 6 359.29 Sodium/glucose cotransporter 2 
DB01132 3.07 68.29 25 356.45 5 1 0 7 318.53 Peroxisome proliferator-activated 
receptor gamma (Agonist) 





92.61 22 298.32 5 3 0 5 269.17  
 
 
Fig. 1: Structure of six sulphonylurea drugs, the common unit has been encircled. Apart from the common aromatic ring, similar to 
peptide bonds, CO-NH groups are placed in trans conformation in five drugs 
 
 
Fig. 2: Predicted structure of target protein represented in 
cartoons form, distinct helix bundle structure expected to form 
the transmembrane region is observed. Helix regions shown in 
red colour constitute 56.2% region of the structure, yellow 
colored strands form 7.6% 
Extracts of the plant Tinospora cordifolia have been used for the 
treatment of many diseases since ancient times. Researchers have 
identified multiple active compounds of the plant, one of which has 
been reported to possess insulin release stimulating effect. While 
activity and compound details have been reported, details of the mode 
of action of the plant metabolite have not been reported [11]. The 
current work focused on the comparison of the natural molecule with 
approved drugs having similar insulin release stimulating effect. 
Sulphonylurea drugs target ATP-binding cassette sub-family C 
member 8 and stimulate insulin release. The potential of natural plant 
metabolite to target ATP-binding cassette sub-family C member 8 seems 
probable based on docking and interaction analysis results. The 
optimum model [fig. 2] of target generated after energy minimization 
had only 1.3% of the non-proline, non-glycine residues in the disallowed 
region of Ramachandran plot whereas, 84.4% residues were found in 
the most favored regions. PDBSum reported a total of 11 pores which 
collectively span through the predicted structure and thus justify the 
function of transport across the membrane. The model predicted also 
has helix bundle structure like most transmembrane protein receptors. 
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Table 2: Summarizes the details of binding affinity and drug-target interaction. Binding energy of the natural molecule is comparable 






DB01124 -5.67 Hydrophobic interaction–L508, L511, Y512, R1418, I1423, L1425, D1427, V1429. Polar contact-R1497, H-bond at 2.84Å. 
DB01251 -6.17 Hydrophobic interaction–K507, L508, L511, Y512, S1385, L 1389, F1392, I1423, L1425, Q1426, D1427, V1429. Polar 
contact-D1505, H-bond at 3.12Å and 2.6Å. 
DB01382 -4.02 Hydrophobic interaction–I60, H61, T64, H67, E88, W514, F1431, S1432, F1437, P1441, D1442. 
DB01252 -6.27 Hydrophobic interaction–L511, Y512, W514, R1418, S1419, P1441, K1444, R1497. 
DB00672 -5.09 Hydrophobic interaction–L511, Y512, R1418, S1419, R1493, R1497. 
DB01016 -3.64 Hydrophobic interaction–W1338, I1456, T1525, A1526, A1528, D1529, R1530. 
DB01120 -4.21 Hydrophobic interaction–N1365, A1366, L1367, L1547, I1556, F1559. 
Natural 
ligand 
-5.57 Hydrophobic interaction–L508, L511, Y512, I1423, L1425, D1427, V1429, R1497. 
 
Though the natural metabolite does not show the best affinity, it is 
comparable with the chemical drugs group. Natural molecules are 
usually preferred as treatment measure because of their minimum 
adverse effects. Tinospora cordifolia is a plant with multiple 
medicinal benefits, and it has also been reported to stimulate insulin 
production. The present study focused on the comparison of active 
compound of Tinospora with drugs having insulin production 
stimulating function. Though it has not shown the best interaction 
with the target protein, however, the binding energy and 
interactions are comparable. This plant metabolite may thus serve 
as a potential lead molecule for further derivatization, optimization, 
and enhanced interaction. 
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